Research On Risk Management Of Innovative Drug Project Of YB Company

With the pace of global economic integration,the competition of Chinese pharmaceutical industry is no longer just the competition between domestic pharmaceutical enterprises,but is pushed into the tide of international pharmaceutical industry to participate in more intense competition.At present,the majority of patents for the treatment of major diseases are in the hands of European and American companies.Whether domestic pharmaceutical enterprises can gain a place in the pharmaceutical market and survive and develop under the severe industrial ecology depends on whether they have independent intellectual property rights for innovative drugs.But as we all know,the research and development of innovative drugs is the most difficult category of drugs in the research and development of new drugs.It has the novelty of components or the new use of treatment.It is the systematic engineering of many interdisciplinary studies,involving complex and elaborate systems.This means that innovative drug research and development projects have high technical barriers,large investment,long cycle,low success rate,and will be affected by various uncertain factors in the research and development process,which makes innovative drug research and development full of risks.Innovative drug research and development of risk management has become a pharmaceutical research and development staff on issues of mutual interest,domestic and foreign experts and scholars from different angles and levels were studied and discussed,mainly including the risk types of new drug research and development research,risk evaluation index system of new drug research and development of research,a specific risk factors,etc.Although China has a certain understanding of the risk management of new drug research and development,it is generally confined to the academic level,especially the risk management theory of innovative drug research and development is relatively general,empirical research is not only few,but also systematic and in-depth.Innovative drugs play an important role in China's national economy and people's livelihood.Scientific and effective risk management of innovative drug research and development projects,reducing or avoiding research and development risks to improve the success rate of innovative drug research and development,can provide more medical possibilities for the society and bring impetus for sustainable development for enterprises.The combination of innovative drug development and risk management is especially important for new drug research organizations and enterprises.YB company is the domestic famous traditional Chinese medicine enterprises,the company with unique Chinese traditional medicine protection products,for many years to maintain high growth momentum,but due to the company for many years of sales over research and development,innovation in product research and development on didn't attach importance to it and layout in advance,so the whole product structure,market growth space appear "ceiling phenomenon",lead to enterprise performance of weak growth in recent years.The research and development of innovative drugs is the key for YB company to break the business dilemma.The decision-making level of the company has gradually realized the importance of innovative drug research and development.Currently,the strategic layout of new drug research and development is "traditional Chinese medicine to maintain the foundation,generic drugs to be the industry,and innovative drugs to seek breakthroughs",The New Deal,but due to the national drug management medicine research and development of the ecological environment,great changes have taken place,YB company due to no innovative drug research for many years,can be drawn lessons from the lack of experience,feeling the stones across the river stage,especially on innovative drug r&d project management risk management appeared many problems,has paid a lot of "tuition".It is urgent and imperative for YB company to strengthen risk management and avoid and reduce risk influence on innovative drug research and development projects.Through the empirical study on the risk management of YB's innovative drug r&d project,this paper found that there were problems in the risk management of YB's innovative drug r&d project,such as the simplification of risk identification methods,the subjectivism of risk assessment,the formalization of risk response,and the limitation of risk control.Through interviews and field investigation,the causes of risk management problems were analyzed,mainly including the lack of efficient organizational structure,imperfect risk management system,weak awareness of modern risk management of leaders,and lack of enterprise risk culture.Finally,according to the actual situation of YB company,the paper applies the theory of risk management to put forward strategies for strengthening risk management and reasonably avoiding risks from the aspects of perfecting risk management identification method,improving risk assessment system,refining risk response strategies,strengthening risk management and control,and integrating internal and external resources.Through the research of this topic,key risk factors were comprehensively identified for the innovative drug r&d of YB company,the risk assessment model based on the analytic hierarchy process(AHP)was established,and the risk control process was proposed to make the risk management more scientific and systematic,and enrich the relevant theories of risk management of innovative drug r&d projects.It provides valuable theoretical basis for the construction of this discipline,and also provides useful reference for pharmaceutical enterprises and r&d organizations to strengthen risk management.